Sunday, June 24, 2018
Company News: Page (1) of 1 - 06/11/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Biobanking Market Forecasts 2018-2028 - Visiongain Report
(June 11, 2018)

LONDON, June 11, 2018 /PRNewswire/ --

Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Stem Cells (Adult Stem Cells, Umbilical Cord), Other applications (DNA, RNA, body fluids), Leading Biobanking Companies and Key Geographies

Biobanking - our new study reveals trends, R&D progress, and predicted revenues

     (Logo: )

Where is the Biobanking market heading? If you are involved in this sector you must read this brand-new report. Visiongain's report shows you the potential revenues streams to 2028, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead
Our 266-page report provides 145 tables, charts, clearly illustrating the data presented in this research. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted drug sales at overall world market regional level, as well as giving a deep insight into the pipeline for Biobanking. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biobanking market. See how to exploit these opportunities.

Forecasts to 2028 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2028, our new study provides you with recent results, R&D overview, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and following Biobanking Submarkets: 

• Biobanking for Research:
• Human Tissue:
- Commercial
- Public
• Stem Cells
• Others (DNA, Blood fluids etc.)

• Biobanking for Therapeutic Use:
• Umbilical Cord Banking
• Adult Stem Cell Banking

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 12 leading national markets:
• US
• Germany
• France
• The UK
• Spain
• Italy
• The Netherlands
• Japan
• China
• India
• Brazil
• Russia
• RoW

Our analysis shows activities of biobanks, including these organisations:
• Stemgent
• Biopta
• BioServe
• Coriell Institute for Medical Research
• Cord Blood America
• Cryo-Cell International.

And other companies, including these:
• China Cord Blood Corp
• LifebankUSA
• ViaCord
• Cord Blood Registry
• Biogenea Pharmaceuticals
• StemLife
• Caladrius Biosciences.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2028.

Leading companies and the potential for market growth
Overall world revenue for Biobanking will surpass $35bn in 2023, our work calculates. This will be driven by the use of biobanking in drug development and medical research, as well as the expected rise in number of commercial biobanks over the forecast period

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Biobanking Market report helps you
In summary, our 266-page report provides you with the following knowledge:
• Revenue forecasts to 2028 for the Biobanking market and Leading Submarkets - discover the industry's prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2028 for 12 of the leading national markets - US, Germany, France, UK, Italy, Spain, Netherlands, Japan, Russia, China, India, Brazil
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market - including company profiles for 16 companies involved in commercial biobanking and biobanking for therapeutic use

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Biobanking market and leading companies. You will find data, trends and predictions.

Get our report today Biobanking Market Forecasts 2018-2028: Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Stem Cells (Adult Stem Cells, Umbilical Cord), Other applications (DNA, RNA, body fluids), Leading Biobanking Companies and Key Geographies. Avoid missing out - get our report now

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website :

Companies Listed 

Abbott Laboratories
AKH Biobank
American CryoStem
American Type Culture Collection
Analytical Biological Services
ARUP Laboratories
ASPREE Healthy Ageing Biobank
Assure Immune
Aurora Biomed
Auto scribe Informatics
Bangalore Brain Bank
Barts Gynae Tissue Bank
Beckman Coulter
Bio Fortis
Bio Life Solutions
Bio Repository Resources
BioServe Biotechnologies
Biovault Technical
BrainNet Europe
Bristol-Myers Squibb
Brooks Automation (acquired Bio Storage Technologies)
Brooks Life Science Systems
Caladrius Biosciences
Cambridge Biomedical Research Centre
Cancer Genetics Inc
CCLG Tissue Bank
Celltex Therapeutics
Cellular Dynamics International Inc
Cesca Therapeutics
China Cord Blood Corp.
China Kadoorie Biobank
CLB/Amsterdam Medical Center
CMD Biobank
Cord Blood America
Cord Life
CORE Informatics
Coriell Institute for Medical Research
Cryo Bio System
Cryo-Cell International
Cryogene Lab
Custom Biogenic Systems
DeCODE Genetics (Amgen)
Eli Lilly
Eli Lilly
Fisher Bio Services
Future Health Biobank
GE Healthcare SeqWright Genomic Services
Haier Biomedical
Hamilton Robotics
Hamilton Storage Technologies
Hospital Necker Paris
Hudson Robotics
Human Longevity Inc
Hungarian Biobank
Huntington Disease Biobank
In biomed
Infectious Disease Biobank
International Stem Cell Corporation
Kaiser Permanente
King's College London Tissue Bank
Lab ware
Leiden Longevity
Leiden University Medical Center
Life Bank USA
Life Gene
Life Lines Biobank
Malm? Microbiology Biobank
Mitochondrial Disease Biobank
Novare Biologistics
Ocimum Bio solutions
OnCore UK
Organisation for Economic Co-operation and Development (OECD)
Pacific Bio Storage
Panasonic Biomedical
Pharma Cells
Pop-Gen National Cohort
Precious Cells
Precision Bio services
Riken BRC Cell Bank
Sapien Biosciences
Smart Cells
Stem Life
Stem Save
System Biosciences
Taiyo Nippon Sanso
TAP Bio systems (now owned by Sartorius Stedim Biotech)
TCG Life Sciences Tissue Bank
Thermo Fisher Scientific
TISS-EU Project
Tissue Solutions
TTP Labtech
UCL Biobank
US Biomax
Via Cord
Virgin Health Bank

To see a report overview please e-mail Sara Peerun on [email protected]

SOURCE Visiongain

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:China,Panasonic,Medicine,Disease,Aging,healthcare,Pregnancy,Surgery,Pregnancy,Science,Communications Technology,Medical,Biology,Genetics,Stem Cell,Cancer,Business,Science,china,Other,
Related Sites: DMN Newswire ,   BN - Panasonic ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines